пятница, 15 января 2016 г.

Merck pays $830 M to settle class-action case over Vioxx

Merck pays $830 M to settle class-action case over Vioxx


Merck will pay $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which the drugmaker pulled from the market years ago over safety concerns. Merck said Friday that the case involved people who purchased its securities between 1999 and 2004.



from Biotech News